RWLK - ReWalk Robotics Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.6300
-0.1700 (-4.47%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close 3.8000
Open 3.7800
Bid 0.0000 x 1200
Ask 4.8800 x 2900
Day's Range 3.5000 - 3.8699
52 Week Range 3.2700 - 33.7500
Volume 1,046,076
Avg. Volume 4,996,593
Market Cap 16.378M
Beta (3Y Monthly) 2.66
PE Ratio (TTM) N/A
EPS (TTM) -14.7200
Earnings Date May 10, 2019 - May 14, 2019
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 6.25
Trade prices are not sourced from all markets
  • Could ReWalk Robotics Ltd.'s (NASDAQ:RWLK) Investor Composition Influence The Stock Price?
    Simply Wall St. 18 hours ago

    Could ReWalk Robotics Ltd.'s (NASDAQ:RWLK) Investor Composition Influence The Stock Price?

    The big shareholder groups in ReWalk Robotics Ltd. (NASDAQ:RWLK) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders...

  • Benzinga 2 days ago

    ReWalk Robotics Higher After First Cigna Insurance Beneficiary Receives Personal 6.0 Exoskeleton

    ReWalk said a Cigna Corp (NYSE: CI) insurance beneficiary in New York became eligible to receive its ReWalk Personal 6.0 exoskeleton. The person had suffered a spinal cord injury in a motorcycle accident in 2016. Cigna revised its policy regarding coverage of exoskeleton medical devices for persons with spinal cord injury in February after having a non-coverage policy previously.

  • ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary
    PR Newswire 2 days ago

    ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 16, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), announced today that the first Cigna Corporation (Cigna) insurance beneficiary has received a ReWalk Personal 6.0 exoskeleton for use at home and in his community. The beneficiary is a New York man who sustained a spinal cord injury in a motorcycle accident in 2016. After learning about ReWalk's technology and going through the proper examinations, he became eligible to receive a ReWalk Personal 6.0 exoskeleton.

  • GlobeNewswire 13 days ago

    ReWalk Robotics Announces Closing of Registered Direct Offering for $4.25 Million Priced At-the-Market

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 816,914 ordinary shares at a purchase price of $5.2025 per ordinary share, priced at-the-market. ReWalk also issued unregistered warrants to purchase up to 408,457 ordinary shares. The warrants have a term of 5.5 years, are exercisable immediately and have an exercise price of $5.14 per ordinary share.

  • GlobeNewswire 14 days ago

    ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 816,914 ordinary shares at a purchase price of $5.2025 per ordinary share in a registered direct offering priced at-the-market. ReWalk will also issue unregistered warrants to purchase up to approximately 408,457 ordinary shares. The warrants will have a term of 5.5 years, be exercisable immediately following the issuance date and have an exercise price of $5.14 per ordinary share.

  • ACCESSWIRE 17 days ago

    Will Your Insurance Pay for a ReWalk Robotics Solution for Paralysis?

    NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on ReWalk Robotics, Ltd. (RWLK), a company that develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury (SCI) or stroke. There is a substantial market for the company's ReWalk exoskeleton for SCI patients in the U.S. with a substantial backlog of demand. On March 26, 2019, the company announced the delivery of a ReWalk Personal 6.0 System to Lucy Dodd, a British children's social care worker paralyzed by a rare spinal condition, which will allow her to stand and walk again.

  • GlobeNewswire 20 days ago

    ReWalk Robotics Completes One-for-Twenty-Five Reverse Share Split

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) reported today that it has completed the reverse share split of ReWalk ordinary share at a ratio of one-for-twenty-five shares, which will take effect on April 1, 2019. The Company also increased its authorized and registered share capital and amended its Articles of Association to reflect the reverse share split and the increase in share capital. Following the reverse share split and increase in authorized share capital, the total number of ordinary shares that the Company is authorized to issue will be 60 million shares, the par value per share of the ordinary shares will be NIS 0.25 and the authorized share capital of the Company will be NIS 15 million.

  • PR Newswire 23 days ago

    British Paraplegic Receives ReWalk Exoskeleton Device After Successful Campaign to Walk Again

    BIRMINGHAM, England and YOKNEAM ILIT, Israel, March 26, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced delivery of a ReWalk Personal 6.0 System to Lucy Dodd, a British children's social care worker paralyzed by a rare spinal condition, which will allow her to stand and walk again. The ReWalk exoskeleton—a medical device designed for individuals with spinal cord injury to be used in the home and the community—is in use throughout the UK and around the world. The system is being delivered following a successful fundraising campaign, led by Dodd and supported by the Association for the Independence of Disabled People (AID), a small Cumbrian charity which aims to improve accessibility in society for the disabled.

  • Should You Be Concerned About ReWalk Robotics Ltd.’s (NASDAQ:RWLK) Historical Volatility?
    Simply Wall St. last month

    Should You Be Concerned About ReWalk Robotics Ltd.’s (NASDAQ:RWLK) Historical Volatility?

    If you're interested in ReWalk Robotics Ltd. (NASDAQ:RWLK), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock couldRead More...

  • GlobeNewswire 2 months ago

    ReWalk Robotics Announces Closing of $4.37 Million Public Offering

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced the closing and funding of its previously announced public offering of 19,000,000 ordinary shares at a price to the public of $0.23 per share. ReWalk intends to use the net proceeds from the offering for (i) sales, marketing and reimbursement expenses related to market development activities and broadening third-party payor coverage and (ii) research and development costs related to, in the shorter term, its ReStore™ exo-suit designed to assist patients who have had a stroke, and, in the longer term, expansion of the Company’s technological platform to address other medical indications affecting the ability to walk. A shelf registration statement on Form S-3 (Registration No. 333-209833) relating to the public offering of the ordinary shares described above was filed by the Company with the Securities and Exchange Commission (the “SEC”) and was declared effective on May 9, 2016.

  • GlobeNewswire 2 months ago

    ReWalk Robotics Announces Pricing of $4.37 Million Public Offering of Ordinary Shares

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced the pricing of a public offering of 19,000,000 ordinary shares, offered at a price to the public of $0.23 per share, for gross proceeds of approximately $4.37 million, before deducting placement agent fees and other estimated offering expenses payable by ReWalk. The offering is expected to close on or about February 25, 2018, subject to customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The offering is being conducted as a “best efforts” offering and the placement agent is not obligated to purchase any securities.

  • GlobeNewswire 2 months ago

    ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced that it intends to offer and sell, subject to market and other conditions, its ordinary shares in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The offering is being conducted as a “best efforts” offering and the placement agent is not obligated to purchase any securities.

  • ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation
    PR Newswire 2 months ago

    ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 19, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the submission of its 510k application to the U.S. Food and Drug Administration (FDA) for the ReStore™ exo-suit for gait training during stroke rehabilitation. Strokes are a major cause of serious long-term disability, with over 795,000 people suffering a stroke each year in the U.S. alone. The soft, garment-like design allows variability of movement in combination with first-of-its-kind active ankle assistance that adaptively synchronizes with the patient's natural gait, to facilitate functional gait training activities.

  • ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices
    PR Newswire 2 months ago

    ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 13, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), disclosed today that Cigna Corporation, a leading global health service company, has revised its policy regarding coverage of exoskeleton medical devices for persons with spinal cord injury (SCI). Cigna, which previously had a non-coverage policy, will now review submissions from beneficiaries on a case-by-case basis to consider providing coverage based on medical criteria. This policy revision is the first of its kind by a major private insurer for individuals eligible to use exoskeleton devices.

  • Thomson Reuters StreetEvents 2 months ago

    Edited Transcript of RWLK earnings conference call or presentation 8-Feb-19 1:30pm GMT

    Q4 2018 Rewalk Robotics Ltd Earnings Call

  • Associated Press 2 months ago

    ReWalk: 4Q Earnings Snapshot

    The Yokneam Ilit, Israel-based company said it had a loss of 10 cents per share. The maker of wearable robotic exoskeletons that help paralyzed patients walk posted revenue of $1.6 million in the period. ...

  • GlobeNewswire 2 months ago

    ReWalk Robotics Reports Fourth Quarter 2018 Financial Results

    — 2018 total revenue of $6.5 million and $1.6 million during the fourth quarter of 2018 —— Preparing for 2019 commercial launch of ReStore for stroke patients — YOKNEAM ILIT,.

  • Have Insiders Been Buying ReWalk Robotics Ltd. (NASDAQ:RWLK) Shares?
    Simply Wall St. 2 months ago

    Have Insiders Been Buying ReWalk Robotics Ltd. (NASDAQ:RWLK) Shares?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We've lost count of how many times Read More...

  • GlobeNewswire 2 months ago

    ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 05, 2019 -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its.

  • ACCESSWIRE 3 months ago

    Watch These 4 Healthcare Stocks Set the Pace on Friday (1/25/19)

    Companies in the healthcare industry have recognized that, as medical experts discover more diseases and ailments, this creates an opportunity to invest in products/services to improve the quality of life for patients. Premier Health Group (OTC:PHGRF) (CSE:PHGI), vTv Therapeutics Inc (VTVT), Canopy Growth Corp (CGC) (WEED.TO), and Rewalk Robotics Ltd (RWLK) represent four healthcare companies determined to invest in the betterment of healthcare. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company focused on developing nuanced approaches that combine human skill-based expertise with up and coming technologies for the healthcare industry to create optimal care solutions for their patients.

  • ACCESSWIRE 3 months ago

    Best Bottom Bouncing Opportunities

    HENDERSON, NV / ACCESSWIRE / January 17, 2019 / Below are some incredible opportunities in the market today. Gopher Protocol Inc. (GOPH) , is an absolutely fascinating company that was trading has a 52-week ...

  • GlobeNewswire 3 months ago

    ReWalk Announces Preliminary Fiscal Year 2018 Revenue

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced preliminary, unaudited revenue for the fiscal year ended December 31, 2018. On a preliminary basis, based on the information currently available, for the fiscal year ended December 31, 2018, the Company expects that total revenue for the year will be approximately $6.5 million. With our clinical study accrual now completed, we plan to finalize our ReStore submission to the U.S Food and Drug Administration shortly,” said Larry Jasinski, Chief Executive Officer of ReWalk.

  • Our Take On ReWalk Robotics Ltd.’s (NASDAQ:RWLK) CEO Salary
    Simply Wall St. 4 months ago

    Our Take On ReWalk Robotics Ltd.’s (NASDAQ:RWLK) CEO Salary

    Larry Jasinski has been the CEO of ReWalk Robotics Ltd. (NASDAQ:RWLK) since 2012. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...

  • Thomson Reuters StreetEvents 4 months ago

    Edited Transcript of RWLK earnings conference call or presentation 8-Nov-18 9:30pm GMT

    Q3 2018 Rewalk Robotics Ltd Earnings Call

  • ACCESSWIRE 4 months ago

    ReWalk Robotics Is Moving Forward with New Funding, Analysts Review and Company Guidance

    NEW YORK, NY / ACCESSWIRE / December 12, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on ReWalk Robotics, Ltd. (RWLK), a company that develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk recently announced a new funding program and will receive aggregate gross proceeds of approximately $12.1 million from the offering. ReWalk intends to use the net proceeds from the offering for sales, marketing and reimbursement expenses related to market development activities and broadening third-party payor coverage, research and development costs related to developing its lightweight ''soft suit'' exoskeleton technology for various lower limb disabilities, including stroke and other indications affecting the ability to walk, and the repayment of certain outstanding indebtedness.